RxDoctor Payments Data

Jennifer Williams Reid, MD

Family Medicine · Middlefield, OHNPI 1396846861

Payments from drug & device makers

$5,254in general payments, 2019–2025

Across 302 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$585
  • Novo Nordisk$440
  • GSK$319
  • Lilly USA, LLC$316
  • AstraZeneca$264
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$5,254100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,254 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$71,319
Medicare patients
190
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter145$120,385
EliquisApixaban112$119,511
TrulicityDulaglutide93$107,358
OzempicSemaglutide88$89,812
JardianceEmpagliflozin74$87,798
MounjaroTirzepatide56$81,854
FarxigaDapagliflozin Propanediol50$44,233
Tresiba Flextouch U-200Insulin Degludec14$37,518
XareltoRivaroxaban14$21,935
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$19,762
RybelsusSemaglutide18$18,814
Janumet XrSitagliptin Phos/Metformin Hcl13$14,079
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr26$12,601
VascepaIcosapent Ethyl25$11,623
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog26$10,970

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$316$189,212149 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$319$142,598187 claims
PfizerEliquis$585$119,511112 claims
Novo NordiskOzempic, Rybelsus$440$108,626106 claims
Boehringer IngelheimJardiance, Tradjenta$238$94,45987 claims
AstraZenecaFarxiga, Breztri Aerosphere$264$63,99562 claims
Johnson & JohnsonXarelto$162$21,93514 claims
MerckJanumet Xr$88$14,07913 claims
Astellas Pharma US IncMyrbetriq$26$5,56012 claims
AbbVieSynthroid$1,090$4,76681 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$11$2,570260 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Middlefield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →